Sign in

CIK 0001269026 · Non-accelerated filer<br>Smaller reporting company

Sintx Technologies, Inc.

Sign in to watch
Ticker
SINT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
801-839-3516
Business address
1885 WEST 2100 STREET, SALT LAKE CITY, UT, 84119
Former names
AMEDICA CORP, AMEDICA Corp
  1. 4 Grant or award President acquired 4,910 shares (grant or award)
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Director bought 8,292 shares at an average $2.91 ($24,092)
  4. 4 Open-market buy Director bought 1,000 shares at $2.91 ($2,910)
  5. 4 Open-market buy Director bought 3,000 shares at $3.02 ($9,060)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy Chief Investment Officer bought 8,200 shares at an average $4.26 ($34,896)
  10. 4 Open-market buy Chief Investment Officer bought 65,000 shares at an average $3.93 ($255,350)
  11. 4 Open-market buy Chief Investment Officer bought 10,000 shares at an average $3.19 ($31,900)
  12. 4 Open-market buy President and CEO bought 5,800 shares at $3.40 ($19,720)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy Director bought 3,000 shares at $3.59 ($10,756)
  16. 4 Open-market buy Chief Investment Officer bought 50,000 shares at an average $3.70 ($185,000)
  17. 4 Open-market buy President and CEO bought 10,475 shares at an average $3.58 ($37,470)
  18. 4 Open-market buy Director bought 10,000 shares at $3.30 ($33,000)
  19. 4 Open-market buy Director bought 5,000 shares at $2.36 ($11,800)
  20. 4 Open-market buy Chief Strategy Officer bought 4,000 shares at $1.79 ($7,160)

Page 1 of 5 · 97 filings